Figure 1.
International Centre for Genomic Medicine in Neuromuscular Disease (ICGNMD) research strategy and SA-specific outcomes. The study, involving four South African academic centres as part of a six-nation global NMD genomic study, is structured in three phases: a clinical fellow training- (1), genomic- (2), and translational phase (3). Green indicates local clinical fellow involvement; red indicates collaborative genomics strategy and purple specific collaborative follow-up studies where novel findings are investigated.